Evidence map›Paper›PMID 26798325›Full record

ArticleClinical and molecular allergy : CMA2016

Interleukin-17-producing decidual CD4+ T cells are not deleterious for human pregnancy when they also produce interleukin-4.

Letizia Lombardelli, Federica Logiodice, Maryse Aguerre-Girr, Ornela Kullolli, Herman Haller, Ysabel Casart, Alain Berrebi, Fatima-Ezzahra L'Faqihi-Olive, Valérie Duplan, Sergio Romagnani and 4 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and molecular allergy : CMA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Benefits of α-lipoic acid in high-risk pregnancies (Review).Experimental and therapeutic medicine · 2021
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Accumulation of IL-17Clinical & translational immunology · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Letizia LombardelliDepartment of Experimental and Clinical Medicine and DENOTHE Excellence Center, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Federica LogiodiceDepartment of Experimental and Clinical Medicine and DENOTHE Excellence Center, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Maryse Aguerre-GirrINSERM UMR1043, CNRS UMR5282, Centre de Physiopathologie Toulouse-Purpan, Université de Toulouse III, 31024 Toulouse, France.
Ornela KullolliDepartment of Experimental and Clinical Medicine and DENOTHE Excellence Center, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Herman HallerDepartment of Gynecology and Obstetrics, Medical Faculty, University of Rijeka, 51000 Rijeka, Croatia.
Ysabel CasartINSERM UMR1043, CNRS UMR5282, Centre de Physiopathologie Toulouse-Purpan, Université de Toulouse III, 31024 Toulouse, France.
Alain BerrebiGynécologie-Obstétrique, Hôpital Paule de Viguier, Toulouse, France.
Fatima-Ezzahra L'Faqihi-OliveINSERM UMR1043, CNRS UMR5282, Centre de Physiopathologie Toulouse-Purpan, Université de Toulouse III, 31024 Toulouse, France.
Valérie DuplanINSERM UMR1043, CNRS UMR5282, Centre de Physiopathologie Toulouse-Purpan, Université de Toulouse III, 31024 Toulouse, France.
Sergio RomagnaniDepartment of Experimental and Clinical Medicine and DENOTHE Excellence Center, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Enrico MaggiDepartment of Experimental and Clinical Medicine and DENOTHE Excellence Center, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
Daniel RukavinaDepartment of Physiology and Immunology, Medical Faculty, University of Rijeka, 51000 Rijeka, Croatia.
Philippe Le BouteillerINSERM UMR1043, CNRS UMR5282, Centre de Physiopathologie Toulouse-Purpan, Université de Toulouse III, 31024 Toulouse, France.
Marie-Pierre PiccinniDepartment of Experimental and Clinical Medicine and DENOTHE Excellence Center, University of Florence, Largo Brambilla 3, 50134 Florence, Italy.
University of Florence · ITInserm · FRUniversity of Rijeka · HRCentre National de la Recherche Scientifique · FRHôpital Paule de Viguier · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTrophoblast expressing paternal HLA-C antigens resemble a semiallograft, and could be rejected by maternal CD4+ T lymphocytes. We examined the possible role in human pregnancy of Th17 cells, known to be involved in allograft rejection and reported for this reason to be responsible for miscarriages. We also studied Th17/Th1 and Th17/Th2 cells never investigated before. We defined for the first time the role of different Th17 subpopulations at the embryo implantation site and the role of HLA-G5, produced by the trophoblast/embryo, on Th17 cell differentiation.

methodsCytokine production by CD4+ purified T cell and T clones from decidua of normal pregnancy, unexplained recurrent abortion, and ectopic pregnancy at both embryo implantation site and distant from that site were analyzed for protein and mRNA production. Antigen-specific T cell lines were derived in the presence and in the absence of HLA-G5.

resultsWe found an associated spontaneous production of IL-17A, IL-17F and IL-4 along with expression of CD161, CCR8 and CCR4 (Th2- and Th17-type markers) in fresh decidua CD4+ T cells during successful pregnancy. There was a prevalence of Th17/Th2 cells (producing IL-17A, IL-17F, IL-22 and IL-4) in the decidua of successful pregnancy, but the exclusive presence of Th17 (producing IL-17A, IL-17F, IL-22) and Th17/Th1 (producing IL-17A, IL-17F, IL-22 and IFN-γ) cells was found in the decidua of unexplained recurrent abortion. More importantly, we observed that Th17/Th2 cells were exclusively present at the embryo implantation site during tubal ectopic pregnancy, and that IL-4, GATA-3, IL-17A, ROR-C mRNA levels increased in tubal biopsies taken from embryo implantation sites, whereas Th17, Th17/Th1 and Th1 cells are exclusively present apart from implantation sites. Moreover, soluble HLA-G5 mediates the development of Th17/Th2 cells by increasing IL-4, IL-17A and IL-17F protein and mRNA production of CD4+ T helper cells.

conclusionNo pathogenic role of decidual Th17 cells during pregnancy was observed. Indeed, a beneficial role for these cells was observed when they also produced IL-4. HLA-G5 could be the key feature of the uterine microenvironment responsible for the development of Th17/Th2 cells, which seem to be crucial for successful embryo implantation.

Indexed as

Ectopic pregnancyIL-17IL-4PregnancySpontaneous abortionTh17

Identifiers

PMID26798325
PMCPMC4721137
OpenAlexW2286080429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.